$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 ... 6 7 8 9 10 11 12 13 14 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Winkler Robert E | VP, Clin Research & ... | Option Exercise | A | 6.45 | 35,000 | 225,750 | 35,000 | |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | A | 6.45 | 35,000 | 225,750 | 35,000 | |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Business Offi ... | Option Exercise | A | 6.45 | 70,000 | 451,500 | 70,000 | |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Intellectual Pr ... | Option Exercise | A | 6.45 | 35,000 | 225,750 | 35,000 | |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 6.45 | 35,000 | 225,750 | 35,000 | |
Feb 17 2012 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 6.45 | 35,000 | 225,750 | 35,000 | |
Aug 15 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | P | 4.20 | 10,000 | 42,000 | 109,867 | 99.9 K to 109.9 K (+10.01 %) |
Sep 21 2011 | FOLD | AMICUS THERAPEUTIC ... | Winkler Robert E | VP, Clin Research & ... | Option Exercise | A | 3.97 | 85,000 | 337,450 | 85,000 | |
Jun 21 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Executive Chairman | Buy | P | 6.04 | 20,000 | 120,800 | 99,867 | 79.9 K to 99.9 K (+25.04 %) |
Jun 21 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Executive Chairman | Gift | G | 0.00 | 10,000 | 0 | 79,867 | 89.9 K to 79.9 K (-11.13 %) |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 6.06 | 35,000 | 212,100 | 35,000 | |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Schaeffer Orlov S Nicole | SVP, HR & Leadershi ... | Option Exercise | A | 6.06 | 60,000 | 363,600 | 60,000 | |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Intellectual Pr ... | Option Exercise | A | 6.06 | 35,000 | 212,100 | 35,000 | |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Lockhart David J | Chief Scientific Of ... | Option Exercise | A | 6.06 | 85,000 | 515,100 | 85,000 | |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 6.06 | 35,000 | 212,100 | 35,000 | |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 6.06 | 70,000 | 424,200 | 70,000 | |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Gilmore Geoffrey | SVP & General Couns ... | Option Exercise | A | 6.06 | 60,000 | 363,600 | 60,000 | |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | A | 6.06 | 35,000 | 212,100 | 35,000 | |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | SVP, Business Opera ... | Option Exercise | A | 6.06 | 60,000 | 363,600 | 60,000 | |
Jun 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 6.06 | 85,000 | 515,100 | 85,000 | |
Jun 14 2011 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Option Exercise | A | 7.51 | 10,000 | 75,100 | 10,000 | |
Jun 14 2011 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 7.51 | 10,000 | 75,100 | 10,000 | |
Jun 14 2011 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 7.51 | 10,000 | 75,100 | 10,000 | |
Jun 14 2011 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 7.51 | 10,000 | 75,100 | 10,000 | |
Jun 14 2011 | FOLD | AMICUS THERAPEUTIC ... | BARKAS ALEXANDER E | Director | Option Exercise | A | 7.51 | 10,000 | 75,100 | 10,000 | |
Jun 14 2011 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 7.51 | 10,000 | 75,100 | 10,000 | |
Jun 14 2011 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 7.51 | 10,000 | 75,100 | 10,000 | |
Jun 14 2011 | FOLD | AMICUS THERAPEUTIC ... | BARRETT M JAMES | Director | Option Exercise | A | 7.51 | 10,000 | 75,100 | 10,000 | |
May 25 2011 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 0.64 | 2,250 | 1,436 | 543 | |
May 25 2011 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 7.50 | 2,250 | 16,875 | 1,708 | 4 K to 1.7 K (-56.85 %) |
May 25 2011 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | M | 0.64 | 2,250 | 1,436 | 3,958 | 1.7 K to 4 K (+131.73 %) |
Apr 19 2011 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Acting CEO & Presid ... | Grant | A | 0.00 | 50,000 | 0 | 106,547 | 56.5 K to 106.5 K (+88.42 %) |
Feb 03 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Gift | G | 0.00 | 5,000 | 0 | 66,634 | 71.6 K to 66.6 K (-6.98 %) |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Schaeffer Orlov S Nicole | SVP, HR & Leadershi ... | Option Exercise | A | 5.96 | 30,000 | 178,800 | 30,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 5.96 | 25,000 | 149,000 | 25,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Intellectual Pr ... | Option Exercise | A | 5.96 | 30,000 | 178,800 | 30,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | A | 5.96 | 50,000 | 298,000 | 50,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Lockhart David J | Chief Scientific Of ... | Option Exercise | A | 5.96 | 50,000 | 298,000 | 50,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 5.96 | 25,000 | 149,000 | 25,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Gilmore Geoffrey | SVP & General Couns ... | Option Exercise | A | 5.96 | 30,000 | 178,800 | 30,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | A | 5.96 | 30,000 | 178,800 | 30,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Option Exercise | A | 5.96 | 120,000 | 715,200 | 120,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | SVP, Business Opera ... | Option Exercise | A | 5.96 | 30,000 | 178,800 | 30,000 | |
Jan 20 2011 | FOLD | AMICUS THERAPEUTIC ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 5.96 | 50,000 | 298,000 | 50,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 2.81 | 12,500 | 35,125 | 12,500 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | VP, Business Operat ... | Option Exercise | A | 2.81 | 20,000 | 56,200 | 20,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Lockhart David J | Chief Scientific Of ... | Option Exercise | A | 2.81 | 30,000 | 84,300 | 30,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | John McAdam M | VP, Finance & Accou ... | Option Exercise | A | 2.81 | 15,000 | 42,150 | 15,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | A | 2.81 | 25,000 | 70,250 | 25,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Schaeffer Orlov S Nicole | SVP, HR & Leadershi ... | Option Exercise | A | 2.81 | 20,000 | 56,200 | 20,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Gilmore Geoffrey | SVP & General Couns ... | Option Exercise | A | 2.81 | 20,000 | 56,200 | 20,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | A | 2.81 | 30,000 | 84,300 | 30,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 2.81 | 30,000 | 84,300 | 30,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Option Exercise | A | 2.81 | 55,000 | 154,550 | 55,000 | |
Jun 17 2010 | FOLD | AMICUS THERAPEUTIC ... | NEFF P SHERRILL | Director | Option Exercise | A | 2.81 | 10,000 | 28,100 | 10,000 | |
Jun 16 2010 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 2.81 | 10,000 | 28,100 | 10,000 | |
Jun 16 2010 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 2.81 | 10,000 | 28,100 | 10,000 | |
Jun 16 2010 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 2.81 | 10,000 | 28,100 | 10,000 | |
Jun 16 2010 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Option Exercise | A | 2.81 | 10,000 | 28,100 | 10,000 | |
Jun 16 2010 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 2.81 | 10,000 | 28,100 | 10,000 | |
Jun 16 2010 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 2.81 | 10,000 | 28,100 | 10,000 | |
Jun 16 2010 | FOLD | AMICUS THERAPEUTIC ... | BARKAS ALEXANDER E | Director | Option Exercise | A | 2.81 | 10,000 | 28,100 | 10,000 | |
Jun 15 2010 | FOLD | AMICUS THERAPEUTIC ... | BARRETT M JAMES | Director | Option Exercise | A | 2.81 | 10,000 | 28,100 | 10,000 | |
Mar 18 2010 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 3.32 | 30,000 | 99,600 | 30,000 | |
Mar 03 2010 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Option Exercise | P | 4.43 | 11,898 | 52,708 | 11,898 | |
Mar 03 2010 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman, President ... | Buy | P | 3.69 | 11,898 | 43,904 | 71,634 | 59.7 K to 71.6 K (+19.92 %) |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | John McAdam M | Corporate Controlle ... | Option Exercise | A | 4.16 | 30,000 | 124,800 | 30,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 4.16 | 35,000 | 145,600 | 35,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | VP, Business Operat ... | Option Exercise | A | 4.16 | 45,000 | 187,200 | 45,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Gilmore Geoffrey | SVP & General Couns ... | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Schaeffer Orlov S Nicole | SVP, HR & Leadershi ... | Option Exercise | A | 4.16 | 45,000 | 187,200 | 45,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 4.16 | 80,000 | 332,800 | 80,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Lockhart David J | Chief Scientific Of ... | Option Exercise | A | 4.16 | 80,000 | 332,800 | 80,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | A | 4.16 | 80,000 | 332,800 | 80,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | A | 4.16 | 150,000 | 624,000 | 150,000 | |
Nov 17 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Gift | G | 0.00 | 10,000 | 0 | 59,736 | 69.7 K to 59.7 K (-14.34 %) |
Nov 05 2009 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Buy | P | 4.13 | 20,000 | 82,600 | 20,000 | 0 to 20 K |
Oct 01 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.75 | 220 | 1,925 | 32,075 | 32.3 K to 32.1 K (-0.68 %) |
Aug 03 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 11.39 | 220 | 2,506 | 32,515 | 32.7 K to 32.5 K (-0.67 %) |
Sep 02 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 9.83 | 220 | 2,163 | 32,295 | 32.5 K to 32.3 K (-0.68 %) |
Jul 16 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.29 | 3,500 | 36,001 | 69,736 | 73.2 K to 69.7 K (-4.78 %) |
Jul 16 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.69 | 6,500 | 69,472 | 73,236 | 79.7 K to 73.2 K (-8.15 %) |
Jul 16 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.28 | 4,748 | 48,819 | 79,736 | 84.5 K to 79.7 K (-5.62 %) |
Jul 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.09 | 800 | 8,069 | 84,484 | 85.3 K to 84.5 K (-0.94 %) |
Jul 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.06 | 200 | 2,011 | 85,284 | 85.5 K to 85.3 K (-0.23 %) |
Jul 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.24 | 1,652 | 16,918 | 85,484 | 87.1 K to 85.5 K (-1.90 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 12.49 | 100 | 1,249 | 87,136 | 87.2 K to 87.1 K (-0.11 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 11.09 | 971 | 10,766 | 87,236 | 88.2 K to 87.2 K (-1.10 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.37 | 11,829 | 122,667 | 88,207 | 100 K to 88.2 K (-11.82 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 11.69 | 412 | 4,814 | 100,036 | 100.4 K to 100 K (-0.41 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 11.15 | 5,788 | 64,525 | 100,448 | 106.2 K to 100.4 K (-5.45 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 11.59 | 10,400 | 120,494 | 106,236 | 116.6 K to 106.2 K (-8.92 %) |
Jul 08 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 10.42 | 3,100 | 32,308 | 116,636 | 119.7 K to 116.6 K (-2.59 %) |
Jul 01 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 11.45 | 220 | 2,519 | 32,735 | 33 K to 32.7 K (-0.67 %) |
Jun 30 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Sr VP, Technical Op ... | Sell | S | 10.54 | 2,500 | 26,348 | 34,040 | 36.5 K to 34 K (-6.84 %) |
Jun 30 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Sr VP, Technical Op ... | Sell | S | 10.00 | 7,498 | 74,980 | 36,540 | 44 K to 36.5 K (-17.03 %) |
Jun 11 2009 | FOLD | AMICUS THERAPEUTIC ... | Topper James N | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 10,000 | |
Jun 11 2009 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 10,000 | |
Jun 11 2009 | FOLD | AMICUS THERAPEUTIC ... | RAAB MICHAEL | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 10,000 | |
Jun 11 2009 | FOLD | AMICUS THERAPEUTIC ... | NEFF P SHERRILL | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 10,000 | |
Jun 11 2009 | FOLD | AMICUS THERAPEUTIC ... | HAYDEN DONALD J JR | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 10,000 | |
Jun 11 2009 | FOLD | AMICUS THERAPEUTIC ... | BARKAS ALEXANDER E | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 10,000 | |
Jun 11 2009 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 10,000 | |
Jun 01 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 6.64 | 220 | 1,461 | 32,955 | 33.2 K to 33 K (-0.66 %) |
May 04 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.95 | 220 | 1,969 | 33,175 | 33.4 K to 33.2 K (-0.66 %) |
Apr 02 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 9.13 | 220 | 2,009 | 33,395 | 33.6 K to 33.4 K (-0.65 %) |
Apr 01 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Sr VP, Technical Op ... | Sell | S | 10.00 | 2 | 20 | 44,038 | 44 K to 44 K (0.00 %) |
Mar 26 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Sr VP, Technical Op ... | Sell | S | 10.00 | 531 | 5,310 | 44,040 | 44.6 K to 44 K (-1.19 %) |
Mar 25 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Sr VP, Technical Op ... | Sell | S | 10.00 | 1,740 | 17,400 | 44,571 | 46.3 K to 44.6 K (-3.76 %) |
Mar 20 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Sr VP, Technical Op ... | Sell | S | 10.00 | 229 | 2,290 | 46,311 | 46.5 K to 46.3 K (-0.49 %) |
Mar 03 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.06 | 220 | 1,773 | 33,615 | 33.8 K to 33.6 K (-0.65 %) |
Mar 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | M | 5.33 | 1,000 | 5,325 | 89,000 | |
Mar 13 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Buy | M | 5.33 | 1,000 | 5,325 | 119,736 | 118.7 K to 119.7 K (+0.84 %) |
Feb 12 2009 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.42 | 69 | 650 | 61,700 | 61.8 K to 61.7 K (-0.11 %) |
Feb 12 2009 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.42 | 1,839 | 17,327 | 1,652,390 | 1.7 M to 1.7 M (-0.11 %) |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Option Exercise | A | 10.36 | 103,500 | 1,072,260 | 103,500 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Shenker Andrew | VP, Clinical Resear ... | Option Exercise | A | 10.36 | 18,000 | 186,480 | 18,000 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Schaeffer Orlov S Nicole | SVP, HR & Leadershi ... | Option Exercise | A | 10.36 | 31,500 | 326,340 | 31,500 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | A | 10.36 | 54,000 | 559,440 | 54,000 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Lockhart David J | Chief Scientific Of ... | Option Exercise | A | 10.36 | 54,000 | 559,440 | 54,000 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Technica ... | Option Exercise | A | 10.36 | 18,000 | 186,480 | 18,000 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Technica ... | Sell | S | 10.00 | 7,500 | 75,000 | 46,540 | 54 K to 46.5 K (-13.88 %) |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | A | 10.36 | 22,500 | 233,100 | 22,500 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Option Exercise | A | 10.36 | 27,000 | 279,720 | 27,000 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Gilmore Geoffrey | SVP & General Couns ... | Option Exercise | A | 10.36 | 31,500 | 326,340 | 31,500 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Option Exercise | A | 10.36 | 54,000 | 559,440 | 54,000 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Boudes Pol F | Chief Medical Offic ... | Option Exercise | A | 10.36 | 100,000 | 1,036,000 | 100,000 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | VP, Business Operat ... | Option Exercise | A | 10.36 | 36,000 | 372,960 | 36,000 | |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | BARER SOL J | Director | Option Exercise | A | 10.36 | 30,000 | 310,800 | 30,000 | |
Feb 03 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.69 | 220 | 1,912 | 33,835 | 34.1 K to 33.8 K (-0.65 %) |
Jan 12 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Option Exercise | M | 0.64 | 4,924 | 3,142 | 0 | |
Jan 12 2009 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Buy | M | 0.64 | 4,924 | 3,142 | 54,040 | 49.1 K to 54 K (+10.03 %) |
Jan 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.00 | 220 | 1,760 | 34,055 | 34.3 K to 34.1 K (-0.64 %) |
Dec 10 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.54 | 108 | 922 | 61,769 | 61.9 K to 61.8 K (-0.17 %) |
Dec 10 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.54 | 2,892 | 24,692 | 1,654,229 | 1.7 M to 1.7 M (-0.17 %) |
Dec 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Option Exercise | M | 0.64 | 20,098 | 12,823 | 0 | |
Dec 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Buy | M | 0.64 | 20,098 | 12,823 | 56,547 | 36.4 K to 56.5 K (+55.14 %) |
Dec 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 1 | 9 | 61,877 | 61.9 K to 61.9 K (0.00 %) |
Dec 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 24 | 204 | 1,657,121 | 1.7 M to 1.7 M (0.00 %) |
Dec 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 56 | 476 | 61,878 | 61.9 K to 61.9 K (-0.09 %) |
Dec 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 1,488 | 12,648 | 1,657,145 | 1.7 M to 1.7 M (-0.09 %) |
Dec 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.90 | 4 | 36 | 1,658,633 | 1.7 M to 1.7 M (0.00 %) |
Dec 02 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 7.98 | 220 | 1,756 | 34,275 | 34.5 K to 34.3 K (-0.64 %) |
Dec 01 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 108 | 918 | 61,934 | 62 K to 61.9 K (-0.17 %) |
Dec 01 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.50 | 2,892 | 24,582 | 1,658,637 | 1.7 M to 1.7 M (-0.17 %) |
Dec 01 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.52 | 108 | 920 | 62,042 | 62.2 K to 62 K (-0.17 %) |
Dec 01 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.52 | 2,892 | 24,631 | 1,661,529 | 1.7 M to 1.7 M (-0.17 %) |
Nov 26 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.52 | 108 | 920 | 62,150 | 62.3 K to 62.2 K (-0.17 %) |
Nov 26 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 8.52 | 2,892 | 24,637 | 1,664,421 | 1.7 M to 1.7 M (-0.17 %) |
Nov 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 9.03 | 108 | 975 | 62,454 | 62.6 K to 62.5 K (-0.17 %) |